Markets:

Overview

News

Currencies

International

Treasuries

CVS Health Corp (NY:CVS)

73.99 -0.82 (-1.10%)

Streaming Delayed Price Updated: 12:46 PM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

67 68 Next >

Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System ↗

November 20, 2024

PBMs Express Scripts, Caremark, and Optum challenge the FTC's administrative proceedings, arguing it violates constitutional rights and threatens the stability of drug pricing.

Via Benzinga

Is CVS Health Stock an Underrated Buy? ↗

November 20, 2024

Via The Motley Fool

1 Great Reason to Buy Realty Income and Hold It Forever ↗

November 20, 2024

Via The Motley Fool

CVS Health Options Trading: A Deep Dive into Market Sentiment ↗

November 19, 2024

Via Benzinga

CVS Health Stock Is Moving Higher Monday: What's Going On? ↗

November 18, 2024

CVS Health Corporation (NYSE: CVS) shares are trading higher Monday after the company announced the addition of four new directors to its board. Here's what you need to know.

Via Benzinga

Analyst Expectations For CVS Health's Future ↗

November 15, 2024

Via Benzinga

Smart Money Is Betting Big In CVS Options ↗

November 08, 2024

Via Benzinga

Third Point Hedge Fund Buys Tesla, Dumps Micron ↗

November 14, 2024

Third Point filed its Form 13F on Thursday, revealing the fund's trades from the prior quarter.

Via Benzinga

2 Beaten-Down Dividend Stocks to Buy and Hold ↗

November 14, 2024

They're down, but they aren't out, at least not in the eyes of patient investors.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 13, 2024

Via Benzinga

Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare ↗

November 09, 2024

Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization.

Via Benzinga

Topics Government

Looking for Passive Income? These 3 High-Yield Dividend Stocks Cut You a Check Monthly. ↗

November 09, 2024

Dividend-paying stocks consistently outperform those that don't pay a dividend.

Via The Motley Fool

Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike ↗

November 07, 2024

The U.S.

Via Benzinga

Dow Jumps Over 1,500 Points To A New High After Trump Win: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone ↗

November 07, 2024

Via Benzinga

Topics Government Stocks

Trump's Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What's Driving Markets Wednesday? ↗

November 06, 2024

An “everything rally” powered Wall Street on Wednesday after the 2024 election results, with Donald Trump emerging as the clear presidential winner.

Via Benzinga

Topics Government

Gold Down Over 2%; CVS Health Shares Jump After Q3 Results ↗

November 06, 2024

Via Benzinga

CVS Health (CVS) Q3 2024 Earnings Call Transcript ↗

November 06, 2024

CVS earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday ↗

November 06, 2024

Via Benzinga

S&P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20% ↗

November 06, 2024

Market surges to record highs after Trump's election, Republicans win Senate majority. Tech and small-caps up, VIX drops 22%.

Via Benzinga

Topics Government Stocks

CVS Health Stock Jumps After Mixed Q3 Earnings, Takes $1.2 Billion Restructuring Charges Hit ↗

November 06, 2024

CVS Health posted Q3 sales of $95.43 billion, driven by gains in Health Care Benefits. The company revised leadership roles and withdrew its 2024 guidance amid financial challenges.

Via Benzinga

CVS Reports Mixed Q3 Results: Revenue Beats Forecast, Earnings Decline ↗

November 06, 2024

CVS Health Corporation reported a 6.3% increase in total revenues for the third quarter of 2024, reaching $95.4 billion.

Via Talk Markets

Dow, Nasdaq Futures Race Higher As Trump Wins White House: DJT, Tesla Shares Surge — Veteran Investor Predicts US Economy Could 'Take Off' ↗

November 06, 2024

U.S. stocks could witness a strong opening on Wednesday after former President Donald Trump emerged victorious after a long-drawn battle with Joe Biden and Kamala Harris.

Via Benzinga

Topics Economy Government Stocks

Dow, Nasdaq Jump Over 1% Ahead Of Election Results: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone ↗

November 06, 2024

Via Benzinga

Topics Stocks

CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday ↗

November 06, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 05, 2024

Via Benzinga

Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving

November 05, 2024

Health insurers face rising costs in Medicare Advantage. Centene and Molina stay profitable by focusing on Medicaid despite high Medical Benefits Ratios.

Via MarketBeat

Is Realty Income a Buy, Sell, or Hold in 2025? ↗

November 05, 2024

This leading REIT could be an attractive dividend play again.

Via The Motley Fool

CVS Health Q3 Earnings Preview: Can The Company Overcome Recent Challenges? ↗

November 04, 2024

CVS Health is preparing to report Q3 earnings after cutting its annual profit guidance and implementing leadership changes.

Via Benzinga

CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 29, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Cigna Considers Humana Acquisition – What It Means for the Stocks

October 29, 2024

Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky.

Via MarketBeat

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

67 68 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.